Riken Vitamin Co., Ltd.JP:4526Income statement

Market cap
¥93B
P/E ratio
13.8x
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue75,39877,56885,41985,60388,07287,18189,51589,88882,97477,72279,23188,75091,48495,582
Revenue growth (%)-
Cost of revenue---61,08562,14959,85462,42763,51055,51555,71153,66661,50661,59864,312
Gross profit---24,51825,92227,32627,08826,37727,45822,01025,56427,24429,88631,270
Gross margin (%)---
Operating margin (%)---
Operating expenses ---19,86619,89320,26520,82321,32421,06920,64319,72320,08520,51422,545
Operating income ---4,6516,0297,0616,2645,0526,3891,3675,8407,1589,3718,724
Income before tax 2,8363,7415,2944,6855,3436,4895,4274,8606,1271,6526,1827,72310,2969,417
Pretax margin (%)3.84.86.25.56.17.46.15.47.42.17.88.711.39.9
Provision for income taxes---1,4511,9551,7922,6542,0701,9041,603-1,2851,4403,1493,314
Effective tax rate (%)---
Net income 1,7592,4762,8643,8004,1504,3565,6403,973-7,802-1,61021,5986,4178,7599,392
Earnings per share62.47106.65162.36171.67187.44270.06345.3240.94-239.48-49.36657.98195.51268.44310.08
Diluted EPS-----269.7345.21-------
Dividend per share-------81844246598194